SCHEMBL4834518

SCHEMBL4834518

COc1ccc2c(c1)C(=O)NC(C)(C)C2O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.45
CA2 P00918 3/20 0.43
CA1 P00915 1/20 0.43
CA4 P22748 1/20 0.43
CA7 P43166 1/20 0.43
CA9 Q16790 1/20 0.43
TP53 P04637 1/20 0.41
ATM Q13315 1/20 0.40
PDE3B Q13370 1/20 0.39
PDE3A Q14432 1/20 0.39
LRRK2 Q5S007 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
MAPT P10636 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
KDM4E B2RXH2 2/20 0.39
NPC1 O15118 1/20 0.39
POLB P06746 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4841025 0.76 HSP90AA1 (0.44) ALDH1A1MAPTMEN1KMT2AKDM4E
SCHEMBL1095905 0.74 HSD17B10 (0.40) ALDH1A1ATMMEN1KMT2AKDM4E
SCHEMBL4839825 0.72 HSP90AA1 (0.39) ALDH1A1CA2CA1MAPTMEN1
SCHEMBL4839837 0.72 HSP90AA1 (0.39) ALDH1A1CA2CA1MAPTMEN1
SCHEMBL4838946 0.70 ALDH1A1 (0.51) ALDH1A1CA2CA1CA4CA7
SCHEMBL31739185 0.70 ALDH1A1 (0.47) ALDH1A1CA2CA1CA4CA7
SCHEMBL28582816 0.69 CA1 (0.56) ALDH1A1CA2CA1CA4CA7
SCHEMBL843721 0.69 PGR (0.42) ALDH1A1CA2CA1CA4CA7
SCHEMBL11288459 0.68 ACHE (0.46) ALDH1A1CA2CA1CA4CA7
SCHEMBL1951724 0.67 ALDH1A1 (0.47) ALDH1A1CA2CA1CA4CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7378428-B2 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2008-05-27 US disclosed
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2005-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient PARK7, MMP8, CDK7 ALDH1A1 2636/4885CA2 2847/4885CA1 2309/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.